Study Monitoring and Site Management

The quality of a clinical trial is determined, in no small part, by what happens at site level. Data that is not collected correctly, protocols that are not followed consistently, and sites that are not supported adequately are among the most common sources of trial delay and regulatory concern.

Our monitoring team works on-site and remotely to maintain oversight of every participating centre, ensuring that data integrity is protected and that any issues are identified and resolved before they become problems.

Get In Touch

What We Do

Study monitoring at Niche is carried out by experienced clinical research associates who understand both the science behind the studies they work on and the regulatory standards they are expected to uphold. We provide monitoring services for Phase I through Phase IV trials, across a range of therapeutic areas. 

Site management goes hand in hand with monitoring. We work with investigator sites to ensure they have what they need to participate effectively, from initial set-up and training through to close-out and archiving. The relationship we build with sites has a direct impact on data quality and recruitment performance.

Flowchart showing eight clinical trial monitoring services in alternating dark blue and light blue boxes with connecting arrows and descriptive text.

How We Work

We develop a monitoring plan for each study that reflects the risk profile of the trial, the experience of the sites involved, and the expectations of the sponsor. Monitoring visits are conducted according to that plan, with clear written reports provided after each visit and outstanding issues tracked to resolution. 

Remote monitoring has become an important complement to on-site visits in recent years. We use centralised monitoring approaches where appropriate, reviewing data in real time and flagging concerns without always needing to be physically present. This reduces burden on sites while maintaining the level of oversight the study requires.

Scope Of Service

  • Site selection visits and feasibility assessments 
  • Site initiation visits and investigator training 
  • Routine on-site monitoring visits 
  • Remote and centralised monitoring 
  • Patient recruitment support 
  • Protocol deviation identification and management
  • Data query resolution 
  • Informed consent review 
  • Investigational product accountability checks 
  • Regulatory document review at site 
  • Safety reporting oversight 
  • Site close-out visits 
  • Archiving support for investigator site files
Download our services guide 
Frequently Asked Questions
On-site monitoring involves a clinical research associate visiting the investigator site in person to review source documents, check regulatory files and meet with site staff. Remote monitoring uses technology to review data and documents without a physical visit. Both approaches have their place, and most well-designed monitoring plans use a combination of the two depending on the risk profile of the study and the performance of individual sites.
Monitoring frequency depends on the study protocol, the complexity of the trial and the performance of each site. A risk-based monitoring plan is developed at the start of each study, which determines the appropriate frequency for both on-site and remote monitoring activity. High-enrolling or higher-risk sites will typically receive more frequent visits.
Yes. We are regularly asked to take over monitoring responsibilities for ongoing studies where the original provider has been unable to continue, or where a sponsor needs additional resource. We have a structured handover process to ensure continuity and will review all existing site files before resuming monitoring activity.

Case Histories

Get our latest news and publications

Sign up to our news letter

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility
chevron-down